PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA

Similar documents
EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES. 14 Victor Babes Street, RO-6600, Iasi, Romania

Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey

Population Collective Effective Dose from Nuclear Medicine procedures in Greece

KEYWORDS: nuclear medicine; gamma camera; radiopharmaceutical activities.

Establishment of Dose Reference Levels for Nuclear Medicine in Sudan

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Release of Patients or Human Research Subjects Administered Radioactive Materials

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Application of 99m Tc Radioisotope in Diagnostic Procedures and Internal Radiation Dose Estimation

Department of Nuclear Medicine with Positron Emission Tomography

Health Concerns Related to Radiation Exposure. of the Female Nuclear Medicine Patient. Michael G. Stabin

AN INTRODUCTION TO NUCLEAR MEDICINE

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

Case 4: 27 yr-old woman with history of kidney stones and hyperparathyroidism.

Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan

Internal Dosimetry of Human Brain for 99m tc and 131 I Using Nuclear Imaging in Bangladesh

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones

Parathyroid Imaging What is best

The Effect of Administered Activity on Patient Radiation dose and Image Quality in SPECT at Korle-Bu Teaching Hospital

weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)

RADIATION PROTECTION N 180

Practice and Risk at Medical Facilities in Agency Operations

Poltechnet GBq, radionuclide generator Sodium pertechnetate ( 99m Tc) solution

Radiopharmaceuticals. Radionuclides in NM. Radionuclides NUCLEAR MEDICINE. Modes of radioactive decays DIAGNOSTIC THERAPY CHEMICAL COMPOUND

The radiotracer 99m Tc-MIBI is not genotoxic for human peripheral blood lymphocytes at diagnostic radioactive dose

Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı

SUMMARY OF PRODUCT CHARACTERISTICS (DTPA)

Nuclear medicine in endocrinology

PHYTACIS. Kit for the preparation of technetium [ 99m Tc] phytate injection USER PACKAGE LEAFLET

SUGGESTED PRESCRIBED DOSAGE LIST

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Technescan MIBI 1 mg, kit for radiopharmaceutical preparation

Time of maximum uptake of Technetium-99m pertechnetate (TcO4) in the thyroid gland and its correlation with thyroid functional status

SUMMARY OF PRODUCT CHARACTERISTICS. for. BRIDATEC, kit for radiopharmaceutical preparation

RADIONUCLIDE STUDIES IN THE MANAGEMENT OF PAINFUL TESTICULAR PATHOLOGY

Atoms for Health. Atoms for Health The. Atoms for Health - Division of Nuclear Health - Dept of Nuclear Aplications P Andreo DIR-NAHU 1

Role of IAEA in Promoting Nuclear Medicine

Journal of Radiation Research and Applied Sciences 8 (2015) 317e322. Available online at ScienceDirect

Basics of nuclear medicine

Contrast Agents and Radiopharmaceuticals 2017

2017 St. Luke's-Roosevelt Nuclear Medicine Department Procedure Catalog. meds

Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer

Sodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents

Click Here to Continue. Click Here to Return to Table of Contents

Guideline on core Summary of Products Characteristics and package leaflet for technetium ( 99m Tc) sestamibi

Australian Per Caput Doses from Diagnostic Imaging and Nuclear Medicine

I-123 Thyroid Scintigraphy

15 Annex - Energy 81. RULEBOOK ON APPLICATION OF IONISING RADIATION SOURCES IN MEDICINE

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

Dr Alfred O Ankrah FCNP

New single photon radiopharmaceuticals for renal scintigraphy

Nuclear medicine in renal scarring

ISEMIR An IAEA Tool for Radiation Protection Optimization in Interventional Cardiology and Industrial Radiography

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

METROLOGY TO SUPPORT INNOVATION IN MOLECULAR RADIOTHERAPY. Glenn Flux

NUCLEAR MEDICINE APC TASK FORCE

Comparison of DMSA Scan 99 m and EC Scan 99 m in Diagnosis of Cortical Defect and Differential Renal Function

Nuclear medicine methods in the urogenital system

2. RADIOPHARMACEUTICALS UTILIZED

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

Warning: The intravenous administration of sodium perchlorate mentioned in this recommendation is a non-registered application.

Optimization of a routine method for bone marrow dose estimation in

The correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy 99m Tc-DTPA study

LYMPHOSCINTIGRAPHY: WHY DO IT?

Radiation Dose Rates from Patients Administrated Radiopharmaceuticals Used for Brain Blood Flow Investigation.

Haifeng Hou, 1,2,3,4 Shu Hu, 5 Rong Fan, 5 Wen Sun, 5 Xiaofei Zhang, 6 and Mei Tian 1,2,3,4. 1. Introduction

Diagnostic Reference Levels (DRLs)

Radionuclide & Radiopharmaceuticals

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

R: March, E D T P A. Kit for the Preparation of Technetium Tc 99m Pentetate Injection. DIAGNOSTIC - For Intravenous Use

Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.

GLUCEPTATE. Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION

Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide)

Gastrointestinal tract

SUMMARY OF PRODUCT CHARACTERISTICS (MIBI)

Outline. SPECT/CT in Parathyroid Disease. Pathophysiology. Current guidelines. SPECT/CT the evidence. SPECT/CT in clinical scenarios

Establishing and Expanding Nuclear Medicine Programes

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin)

Madan M. Rehani, Pedro Ortiz López International Atomic Energy Agency Vienna, Austria

RADIOPHARMACEUTICALS AND DRUGS ELIGIBLE FOR CONTINUED SEPARATE MEDICARE PAYMENT ( 2 TO 3 Year Transitional Period )

Comparative Study Between 99m Tc-MDP and 99m Tc-DTPA as a Predictor For Renal Function

Nuclear Medicine in the Diabetic Foot

RadTool Nuclear Medicine Flash Facts

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

György HEVESY ( ) 1943 Nobel Laureate in Chemistry for his work on the use of isotopes as tracers in the study of chemical processes

Evening session 1 Stakeholder platform opportunity 18:30-20:00 IAEA International Atomic Energy Agency

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist

Exposure of the Belgian Population to Ionizing Radiation

Option D: Medicinal Chemistry

STAMICIS 1 mg Kit for radiopharmaceutical preparation

A Snapshot on Nuclear Cardiac Imaging

Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA

Part 7: Regulatory Issues and Quality Control. Part 1: Current NRC Regulations Related to Radiation Safety

Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast.

Primary hyperparathyroidism (HPT) has an incidence of

MYOCARDIAL IMAGING THE REEVALUATION OF MIBI AS THE LIGAND OF

History and Perspectives of Nuclear Medicine in Thailand

Madam President, Director General of the IAEA Excellencies Distinguished Delegates

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Transcription:

PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA Vaida Grigonienė, A. Čepulienė, F. Sakalauskas, J. Marcinkevičius, J. Žiliukas Kaunas, 2012 1

Radiation protection Efficient radiation protection includes the elimination of unnecessary or unproductive radiation exposure. According to Basic Safety Standard all countries should constrain the diagnostic reference levels (DRLs). DRLs are expressed in administered activities (MBq). 2

Diagnostic reference levels in Lithuania DRLs have to be established for the most frequent examinations. Periodically these DRLs have to be reviewed and updated, if it is need. DRLs incorporated into Lithuanian legislation are taken from [1]. DRLs in Lithuania were not reviewed until now. [1] International Atomic Energy Agency (IAEA). Applying Radiation Safety Standards in Nuclear Medicine Safety Report series No. 40. Vienna, 2005. 3

Data collection Data about diagnostic nuclear medicine examinations and patient were collected from all NM centers. In the survey were included 6 body localizations for which NM examinations are performed mostly in Lithuania: bone, kidney, thyroid, parathyroid, heart and lung. 4

Average activity calculation All data were grouped according to examined organ and used radiopharmaceuticals (RF). Average administered activity per examination was estimated in each NM center and compared between them. Later was estimated arithmetic average of administered activity per examination in Lithuania. Average activities per diagnostic nuclear medicine examination were compared with DRLs of Lithuania and seven other countries. 5

Patients effective dose calculation Patients effective doses were estimated using conservative method. S ef =k*a k- conversion coefficients (msv/mbq), A administered activity (MBq) This method does not evaluate individual patient s characteristics and all patients are equated to standard patient. Patients effective doses due to various NM examinations were compared between NM centers. Average patients effective doses of most popular NM examinations were calculated in Lithuania too. 6

Most frequent NM examinations in Lithuania It is performed from 3 to 26 different examinations in one NM center in Lithuania. 16951 diagnostic nuclear medicine examinations of bone, kidney, myocardial, lung, thyroid and parathyroid were performed in Lithuania in 2011 according to NM centers given information. Most frequent examinations are bone (31%), kidney (28%) and thyroid (25%) examinations. Fig. 1. Distribution of bone, kidney, thyroid, parathyroid, Myocardial, lung NM examinations in 2011 year. 7

Radiopharmaceuticals Radiopharmaceuticals usage depends on few circumstances: its properties, NM center specialization, type of equipment in NM center and national insurance health fund financing. Were analyzed 10 radiopharmaceuticals used for NM examinations of 6 most popular body localizations : 99mTc - MAG3, 99mTc DTPA, 99mTc MDP, 99mTc MIBI, 99mTc pertechnetate, 99mTc MYO, 99mTc MAA, 99mTc DMSA, 131I hipuran, 131I sodium iodide. 8

Radiopharmaceuticals distribution in Lithuania The most frequent radionuclide is 99mTc, 87% used radiopharmaceuticals are labeled with it, and only 13% are labeled with 131I. According to literature frequency of radiopharmaceuticals with 99mTc radionuclide increased about 50% in the last ten years*. * L. Kid. Cures for Patients, Nuclear Engineering International, 2008. 9

Administered activity I Administered activity to patient depends on few factors: examination, patient s physical and pathological condition and type of equipment. Administered activity can vary even for the same examination, but different patients. The most important is, that administered activity would be optimized - a view has to be good enough to make accurate diagnose while patient dose is minimal. 10

Administered activity II Administered activity per NM examination can vary up to two times if the same examination is performed with the same RF in different NM centers. The average activity is 108 MBq in this case, but generally results are very scattered (the biggest deviation from average is 63% and the less 24%). 11

Medium, minimum and maximum administered activity for patients performing NM examinations of 6 most popular body localizations in Lithuanian NM centers 12

Medium, minimum and maximum administered activity for patients performing thyroid scintigraphy NM examination in Lithuanian NM centers The biggest differences are between big and little nuclear medicine centers. Probably the biggest influence is done by type of equipment. 13

Average, maximal and minimal administered activity to patients performing different nuclear medicine examinations in Lithuania centers. Examination Radiopharmaceutical Average activity, MBq Max. activity, MBq Min. activity, MBq Bone 99m Tc MDP 517 690 380 Kidney 131 I-hipuranas 366 99m Tc DTPA 108 200 40 99m Tc MAG3 129 176 80 Thyroid Na 131 I 63 320 3 TcO 4-92 150 78 Parathyroid 99m Tc MIBI 347 600 77 Heart 99m Tc MIBI 581 640 500 99m Tc MYO 700 700 700 Lungs 99m Tc MIBI 682 740 650 14

Average patient s effective doses per examination 15

Comparison of average administered activity per NM examination in NM centers with Lithuanian DRLs 16

Comparison of average administered activity per NM examination in NM centers with Lithuanian and 7 others countries DRLs (I) 17

Comparison of average administered activity per NM examination in NM centers with Lithuanian and 7 others countries DRLs (II) 18

Conclusions Administered activities to patient in Lithuania are one of the smallest. Lithuanian practitioners considers to individual patient physical parameters before RF administer. It need to continue the data collecting about diagnostic nuclear medicine examinations to standard patients. Only then would be possible to evaluate DRLs optimally in Lithuania. 19

Thank You 20